Atlas Trials

A Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension -AYAME Study-

Clinical trial NCT02623738 · COMPLETED

Trial details

NCT number
NCT02623738
Sponsor
Santen Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Primary Open Angle GlaucomaOcular Hypertension
Start date
2015-12-06
Primary completion
2017-02-10
Enrollment
253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.